The results of the present study revealed a significant increase in the gene expression levels of NLRP3, ASC, and caspase-1 along with elevated serum levels of IL-1β in RRMS patients compared to healthy controls. This evidence concerns the gene NLRP3 and relapsing-remitting multiple sclerosis.